India approves two more Kovid-19 Sanjeevani Booti, CORBEVAX and COVOVAX for emergency use
New Delhi: Union Health Minister Mansukh Mandaviya on Tuesday, December 28, 2021 informed that the Central Drugs Standard Control Organization (CDSCO) has approved the Emergency Use Authorization (EUA) for two COVID-19 vaccines namely Kovovax and Corbevax. . Minister Mansukh Mandaviya also said on Twitter that Molnupiravir, an anti-viral drug, has also been approved for restricted use in emergency situations. CORBEVAX is India’s first indigenously developed RBD protein sub-unit vaccine against COVID-19 and will be made by Hyderabad-based firm Biological-E. (two more vaccine )
Congratulations India
Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:
– CORBEVAX vaccine
– COVOVAX vaccine
– Anti-viral drug MolnupiravirFor restricted use in emergency situation. (1/5)
— Dr. Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
The Nanoparticle Vaccine, COVOVAX, will be manufactured by Pune-based firm Serum Institute of India. (3/5)
— Dr. Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
Also read: PM Narendra Modi got India’s most expensive Mercedes-Maybach worth Rs 12 crore, this is a special feature with the blasts
COVOVAX to be manufactured in Pune
COVOVAX, a nanoparticle vaccine, will be manufactured by Pune-based firm Serum Institute of India. Molnupiravir, which is an antiviral drug, will be manufactured by 13 companies in the country for restricted use in emergency situations to treat adult patients with COVID-19 who are at high risk of developing the disease. Union Minister Mansukh Mandaviya tweeted that Prime Minister Narendra Modi ji has led the fight against Kovid-19 from the front. All these approvals will further strengthen the global fight against the pandemic. Our pharma industry is an asset to the whole world.
PM @NarendraModi Ji has led the battle against #COVID19 from the front. All these approvals will further strengthen the global fight against the pandemic.
Our Pharma Industries are asset for the entire world.
May all live happily
Survey Santu Niramayah. (5/5)— Dr. Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
Number of vaccines increased to eight in India (two more vaccines)
With this, the number of vaccines that have received emergency use authorization in India has now risen to eight. So far, Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Zydus Cadila’s ZyCoV-D, Russia’s Sputnik V and US-made Moderna and Johnson & Johnson have received emergency use authorization. With this the vaccination campaign is going on in India. In which a large number of vaccinations have been completed. Recently India has achieved a milestone in Corona Vaccination. The new corona virus Omicron has reached India. Since then the governments have started taking strictness. Night curfew has been announced in states including Delhi, UP. ( two more vaccine )
